Globus Medical (GMED) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
February 21, 2019 4:16 PM ESTAUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2018.
Fourth Quarter:
Worldwide sales increased 11.3% as reported to $195.9 millionFourth quarter net income was $36.8 million, or 18.8% of sales.Diluted earnings per share (EPS) were $0.36Non-GAAP diluted EPS were $0.43Non-GAAP adjusted EBITDA was 34.1% of salesFull Year 2018:
Worldwide sales increased 12.1% as reported to $713.0 millionNet income... More